Blood Samples for the Study of Peanut, Tree Nut and Other Food Allergies
Part of paid clinical trials in Denver, Colorado.
- Sponsor
- University of Colorado, Denver
- Study ID
- NCT02192866
- Status
- Recruiting
Conditions
- Other Food Allergies
- Peanut Allergies
- Tree Nut Allergies
Eligibility Criteria
- Sex
- ALL
- Age
- 1 Year - 75 Years
- Healthy Volunteers
- Accepted
Study Details
Food allergies are now a major problem. These experiments involve getting blood from people with food allergies and from people without food allergies. The blood collected will be used to answer questions and find information about peanut and other food allergies. Samples will come from: * People signed up by the investigators at the University of Colorado Denver * University of North Carolina, Massachusetts General Hospital, Children's Hospital of Colorado and the Immune Tolerance Network (Benaroya Research Institute) where people have been treated for peanut allergies * University of North Carolina, Massachusetts General Hospital, National Jewish Health and The Children's Hospital in Denver where people have taken part or will take part in clinically indicated oral food challenges. Blood and health histories from the University of North Carolina, Massachusetts General Hospital, National Jewish Health, The Children's Hospital and the Immune Tolerance Network will not have personal information linked. The specific aims of this experiment are: 1. Come up with a lab test that will predict how bad an allergic reaction will be to peanuts. 2. Find out what part of a peanut causes allergic reactions. 3. Come up with preventions that can block peanut allergies. 4. Find the strongest proteins in walnuts.
Key Dates
- Start date
- Feb 28, 2014
- Status verified
- Dec 2022
- Primary completion
- Dec 31, 2030
- Completion
- Dec 31, 2030
Study Design
- Enrollment
- 270 participants (estimated)
Arms
- Arm: Peanut allergicNo intervention(s) to be administered.
- Arm: Other food allergicNo intervention(s) to be administered.
- Arm: ControlsNo intervention(s) to be administered.
Primary Outcome Measure
Identify which traits are associated with severe food allergy. [ Time Frame: 1 day of single blood draw ]
Central Contacts
- Stephen Dreskin, MD, PhD303-724-7190
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Colorado School of Medicine | Denver | Colorado | 80045 |
Find similar trials in Denver, CO
Related Studies
- Study to Evaluate the Safety, Pharmacokinetic, and Pharmacodynamic Effects of MY006 in Healthy Volunteers and Patients With Peanut AllergyPHASE1 · Recruiting · Mabylon AG · Colorado Springs, Colorado
- UNC Cashew Sublingual ImmunotherapyPHASE2 · Not Yet Recruiting · University of North Carolina, Chapel Hill · Chapel Hill, North Carolina